Please use this identifier to cite or link to this item:
Title: Omalizumab as a Therapeutic Option for Nasal Polyposis in Moderate-to-Severe Persistent Allergic Asthma: Evidence From a Prospective Study in a Real-World Setting.
Issue Date: 3-Jun-2020
Citation: J Investig Allergol Clin Immunol.2020;(30)6:470-472
PMID: 32490823
ISSN: 1018-9068
Appears in Collections:Hospitales > H. U. Tajo > Artículos

Files in This Item:
The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.